FDA Gives Emergency Authorization to COVID-19 Drug Being Tested by UT Health San Antonio, University Hospital
May 04, 2020
May 04, 2020
SAN ANTONIO, Texas, May 4 -- The University of Texas Health Science Center at San Antonio issued the following news release:
The FDA on May 1 gave emergency authorization to a new anti-viral drug to treat patients with COVID-19. The announcement was made during an afternoon news conference by President Trump. It comes two days after the National Institute of Allergy and Infectious Diseases (NIAID) released preliminary results of a national clinical trial showing that the new drug, r . . .
The FDA on May 1 gave emergency authorization to a new anti-viral drug to treat patients with COVID-19. The announcement was made during an afternoon news conference by President Trump. It comes two days after the National Institute of Allergy and Infectious Diseases (NIAID) released preliminary results of a national clinical trial showing that the new drug, r . . .